CDC73 and parathyroid gland carcinoma: The CDC73 mutation carriers demand particular attention due to a substantially increased lifetime risk of parathyroid carcinoma (15-20% in adults), warranting a low threshold for en-bloc resection if malignancy is suspected and necessitating long-term vigilance (99).